Methodology 129 COPD patients and 90 age-and sex-matched controls were recruited for the study. Genomic DNA was isolated from blood samples. PCR-RFLP of codon 54 and 57 of the MBL2 were studied using enzymes BanI and MboII respectively. In addition to this, serum MDA concentrations were evaluated by TBA-TCA-HCl method. Genotypic distribution was compared by odds ratio statistics using medcal software. Differences in MDA concentrations were analyzed by student's't' test using SPSS version 18.0 (IL, USA, and Chicago).
Results
The genotypic frequencies of codon 54 in COPD patients were significantly higher (p< 0.05) than that of controls. GG genotype was found to be more prevalent in cases (OR= 3.402; CI= 1.14-10.10; p< 0.05). However, there was no significant difference in genotypic distribution for codon 57 of MBL2 gene. Serum MDA concentrations were significantly (p< 0.001) higher in patients (9.00 ±2.906) as compare to controls (6.31±2.361).
Conclusion
The results of the present study revealed that MBL2 polymorphism may be involved in pathogenesis of COPD.
